☆ 4.1 Article

Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Medicine, General & Internal

Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study

Raquel Lopez-Galvez et al.

Summary: In AF patients on long-term rivaroxaban therapy, no decline in renal function was observed and there was even a slight improvement in patients with renal impairment. These findings suggest that rivaroxaban may be a safe option for patients with renal impairment.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2022)

添加到收藏夹

Article Clinical Neurology

Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge

Giuseppe Lippi et al.

Summary: Atrial fibrillation is the most frequent cardiac arrhythmia and is increasing in incidence and prevalence worldwide, especially in countries with middle socio-demographic index. The condition poses a significant economic burden and public health challenge in the future.

INTERNATIONAL JOURNAL OF STROKE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Gerhard Hindricks et al.

EUROPEAN HEART JOURNAL (2021)

添加到收藏夹

Review Medicine, General & Internal

The Multifaceted Interplay between Atrial Fibrillation and Myocardial Infarction: A Review

Alban Belkouche et al.

Summary: This review highlights the complex relationship between atrial fibrillation and myocardial infarction, with AF being a common trigger for different types of MI. AF plays a crucial role in the pathogenesis of MI and requires specific management.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Effect of concomitant antiplatelet therapy on ischemic and hemorrhagic events in patients taking oral anticoagulants for nonvalvular atrial fibrillation in daily clinical practice

Takeshi Morimoto et al.

Summary: Recent randomized clinical trials in Japan showed that combination of oral anticoagulants (OACs) and antiplatelets did not prevent ischemic events but significantly increased major bleedings in patients with nonvalvular atrial fibrillation (NVAF) and concomitant coronary artery diseases (CAD).

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2021)

添加到收藏夹

Article Health Care Sciences & Services

Thromboembolic and bleeding events with rivaroxaban in clinical practice in Spain: impact of inappropriate doses (the EMIR study)

Marcelo Sanmartin Fernandez et al.

Summary: In clinical practice, most patients receive the appropriate dosage of rivaroxaban. However, older age and renal insufficiency are associated with inadequate dosing. Underdosed patients had a slightly higher all-cause mortality rate, while overdosed patients had a higher rate of bleeding events.

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2021)

添加到收藏夹

Article Education, Scientific Disciplines

Rivaroxaban for cancer-associated venous thromboembolism

Bo Liang et al.

Summary: Rivaroxaban is effective in reducing recurrent VTE and shows good safety outcomes in cancer patients. Further randomized controlled trials are needed to confirm these results.

SCIENCE PROGRESS (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Bleeding and Subsequent Cardiovascular Events and Death in Atrial Fibrillation With Stable Coronary Artery Disease

Koichi Kaikita et al.

Summary: In patients with atrial fibrillation and stable coronary artery disease, major bleeding is strongly associated with subsequent major adverse cardiac and cerebrovascular events (MACCE), especially within 30 days after the bleeding event.

CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Stroke prevention strategies in high-risk patients with atrial fibrillation

Agnieszka Kotalczyk et al.

Summary: Effective stroke prevention with oral anticoagulation is essential for managing patients with atrial fibrillation, but caution is needed for patients at high risk of stroke and bleeding. Strategies such as left atrial appendage occlusion are emerging as important non-pharmacological interventions for stroke prevention in these high-risk patients.

NATURE REVIEWS CARDIOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and coronary or peripheral artery disease

Craig Coleman et al.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Four-year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation

Benjamin Miao et al.

CLINICAL CARDIOLOGY (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score

Rachel M. Kaplan et al.

CIRCULATION (2019)

添加到收藏夹

Article Medicine, General & Internal

Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease

Satoshi Yasuda et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The interplay between atrial fibrillation and heart failure on long-term mortality and length of stay: Insights from the, United Kingdom ACALM registry

Oliver J. Ziff et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF

Adam S. Barnett et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)

添加到收藏夹

Review Pharmacology & Pharmacy

Direct oral anticoagulants and cardiovascular prevention in patients with nonvalvular atrial fibrillation

Francisco Marin et al.

EXPERT OPINION ON PHARMACOTHERAPY (2017)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

Assessing generalizability of trial results in general practice

Sean D. Pokorney et al.

EUROPEAN HEART JOURNAL (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation

A. John Camm et al.

EUROPEAN HEART JOURNAL (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial

Rohan Shah et al.

AMERICAN HEART JOURNAL (2016)

添加到收藏夹

Article Medicine, General & Internal

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

C. Michael Gibson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms

Francesco Violi et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial

Kenneth W. Mahaffey et al.

EUROPEAN HEART JOURNAL (2014)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF

William Schuyler Jones et al.

EUROPEAN HEART JOURNAL (2014)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Rivaroxaban and risk of myocardial infarction: insights from a meta- analysis and trial sequential analysis of randomized clinical trials

Saurav Chatterjee et al.

CORONARY ARTERY DISEASE (2013)

添加到收藏夹

Article Clinical Neurology

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF

Graeme J. Hankey et al.

LANCET NEUROLOGY (2012)

添加到收藏夹

Article Medicine, General & Internal

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

添加到收藏夹

Article Hematology

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients

S Schulman et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.